Literature DB >> 19727295

Biomarkers for the identification and treatment of dementia.

Steven D Targum1.   

Abstract

Entities:  

Year:  2008        PMID: 19727295      PMCID: PMC2731690     

Source DB:  PubMed          Journal:  Psychiatry (Edgmont)        ISSN: 1550-5952


× No keyword cloud information.
  11 in total

Review 1.  From anticholinesterase toxicity to Alzheimer's disease: important interactions of cholinergic and NMDA receptor systems.

Authors:  E Jon Popke
Journal:  Toxicol Sci       Date:  2003-04       Impact factor: 4.849

2.  Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults.

Authors:  Anne M Fagan; Catherine M Roe; Chengjie Xiong; Mark A Mintun; John C Morris; David M Holtzman
Journal:  Arch Neurol       Date:  2007-01-08

Review 3.  Biomarkers in the diagnosis of Alzheimer's disease: are we ready?

Authors:  Trey Sunderland; Harald Hampel; Masatoshi Takeda; Karen T Putnam; Robert M Cohen
Journal:  J Geriatr Psychiatry Neurol       Date:  2006-09       Impact factor: 2.680

4.  Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI.

Authors:  M Ewers; K Buerger; S J Teipel; P Scheltens; J Schröder; R P Zinkowski; F H Bouwman; P Schönknecht; N S M Schoonenboom; N Andreasen; A Wallin; J F DeBernardis; D J Kerkman; B Heindl; K Blennow; H Hampel
Journal:  Neurology       Date:  2007-12-11       Impact factor: 9.910

5.  Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study.

Authors:  Oskar Hansson; Henrik Zetterberg; Peder Buchhave; Elisabet Londos; Kaj Blennow; Lennart Minthon
Journal:  Lancet Neurol       Date:  2006-03       Impact factor: 44.182

Review 6.  Biomarkers for early detection of Alzheimer pathology.

Authors:  C M Clark; C Davatzikos; A Borthakur; A Newberg; S Leight; V M-Y Lee; J Q Trojanowski
Journal:  Neurosignals       Date:  2007-12-05

Review 7.  Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease.

Authors:  M J de Leon; L Mosconi; K Blennow; S DeSanti; R Zinkowski; P D Mehta; D Pratico; W Tsui; L A Saint Louis; L Sobanska; M Brys; Y Li; K Rich; J Rinne; H Rusinek
Journal:  Ann N Y Acad Sci       Date:  2007-02       Impact factor: 5.691

8.  Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins.

Authors:  Sandip Ray; Markus Britschgi; Charles Herbert; Yoshiko Takeda-Uchimura; Adam Boxer; Kaj Blennow; Leah F Friedman; Douglas R Galasko; Marek Jutel; Anna Karydas; Jeffrey A Kaye; Jerzy Leszek; Bruce L Miller; Lennart Minthon; Joseph F Quinn; Gil D Rabinovici; William H Robinson; Marwan N Sabbagh; Yuen T So; D Larry Sparks; Massimo Tabaton; Jared Tinklenberg; Jerome A Yesavage; Robert Tibshirani; Tony Wyss-Coray
Journal:  Nat Med       Date:  2007-10-14       Impact factor: 53.440

Review 9.  Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics.

Authors:  Leslie M Shaw; Magdalena Korecka; Christopher M Clark; Virginia M-Y Lee; John Q Trojanowski
Journal:  Nat Rev Drug Discov       Date:  2007-03-09       Impact factor: 84.694

10.  Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial.

Authors:  S Gilman; M Koller; R S Black; L Jenkins; S G Griffith; N C Fox; L Eisner; L Kirby; M Boada Rovira; F Forette; J-M Orgogozo
Journal:  Neurology       Date:  2005-05-10       Impact factor: 9.910

View more
  1 in total

Review 1.  Novel Trends in Electrochemical Biosensors for Early Diagnosis of Alzheimer's Disease.

Authors:  Pavla Valkova; Miroslav Pohanka
Journal:  Int J Anal Chem       Date:  2021-09-01       Impact factor: 1.885

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.